Year: 2025
Type: article
Study design: Observational Study
Abstract: This cohort study examines whether international health technology assessment reviews may identify oncology drugs that are suitable for aggressive price negotiation.
Source: JAMA Network Open
Authors: Stephanie Wang, Alexander C. Egilman, Georg Hahn, Aaron S. Kesselheim
Institutions: Brigham and Women's Hospital, Harvard University
Language: English
Subfield: Economics and Econometrics
Domain: Social Sciences
Open Access status: gold
Estimated APC paid: $3,000
Funders: Kaiser Permanente, Arnold Ventures
OpenAlex ID: W4409160831